Brief: Shineco Enters Letter Of Intent To Acquire Controlling Interest In Changzhou Biowin Pharmaceutical Co
27/07/2020 14:08
July 27 (Reuters) - Shineco Inc TYHT.O :
* SHINECO, INC. ENTERS INTO A LETTER OF INTENT TO ACQUIRE
CONTROLLING INTEREST IN CHANGZHOU BIOWIN PHARMACEUTICAL CO., LTD
* SHINECO INC - UNDER NON-BINDING LOI, CO PROPOSED TO
ACQUIRE
73.7% OWNERSHIP OF CBP BY ISSUING COMMON SHARES WORTH NO MORE
THAN USD25 MILLION
Source text for Eikon: ID:nGNX5JWWkC
Further company coverage: TYHT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shineco
See all newsBrief: Shineco Unveils World's First On-Chain Cell Asset Tokenization Platform Strategic Acquisition Expands Global Blockchain-Biotech Network
Brief: Shineco Establishes Biological Cell Digital Division to Integrate Biological Cell Assets and Blockchain Technology
Brief: Shineco Inc To Effect 50:1 Reverse Stock Split
Brief: Shineco Inc - To Sell 18 Million Shares At $0.75 Each
Brief: Shineco Announces Acquisition Of Singapore Evolutionary Stem Cell Company